Market assessment to improve fibre recycling within the EU textile sector.

Clothing is one of the primary human needs, but today's business models turned most apparel into a disposable product. As a matter of fact, the rising demand results in the production of Millions of tons of textile waste every year which is either landfilled, incinerated or exported, with only small amounts being recycled. One promising recycling attempt towards a circular economy in the apparel sector is fibre-to-fibre recycling, where end-of-use clothes serve as input material for the production of new fibres and, eventually, new apparel. In this work, together with fashion brands and a textile research organisation, a mapping of the market situation and the economic boundary conditions regarding textile fibre recycling are presented. Generally, fibre-to-fibre recycling technologies need more public attention and intensive research, and development is necessary as well as legislative instruments that encourage interest in textile recycling. The market situation for recycled fibres is promising and will tend to an increased demand in recycled fibres in the future. Mandatory certification ensures a sustainable product and fast fashion should be held back. Textile waste landfilling, export regulations as well as sustainable lifestyle education shall be considered by EU legislature to ensure that recycling materials are actually used and create a market pull for textile waste back into the industry.

[Development Status of Integrated PET/MR Products].

Integrated PET/MR is one of cutting-edge technologies in functional and molecular imaging. A review of the current development status of integrated PET/MR products can provide inspiration and promote the development of related fields. This study introduced the technical characteristics and research and development difficulties of integrated PET/MR products from both hardware and software aspects, summarized the publication of English and Chinese papers related to the clinical application of PET/MR products from 2008 to 2022, analysed the differences and current status of clinical application of integrated PET/MR products at home and abroad, and pointed out the development status and direction of integrated PET/MR products in China. Finally, the development of integrated PET/MR products was discussed in terms of technology, clinical application prospects, and market strategies.

The financial situation before and after first-time psychiatric in-patient diagnosis of schizophrenia spectrum, bipolar, and major depressive disorder.

Schizophrenia spectrum, bipolar, and major depressive disorders are severe mental illnesses (SMIs) that not only entail great suffering for those affected but also major societal costs. In this study, I use administrative register data to provide a detailed picture of the financial situation of people with SMI in Sweden during a period of ±10 years around first-time psychiatric in-patient diagnosis of schizophrenia spectrum, bipolar, and major depressive disorders. Receiving a diagnosis was associated with a considerable drop in earnings, which was largely compensated for by social transfers: mainly sickness and disability insurance. However, there were also large and increasing pre-diagnosis earnings gaps, relative to matched comparison groups, especially among those with schizophrenia spectrum disorders. These gaps were to a lesser extent compensated for by social transfers. Consequently, there were permanent and increasing - due to lost earnings growth - income differentials. Hence, findings in previous studies are confirmed: even in an advanced welfare state, people with SMI - especially those with schizophrenia - have an extremely weak position on the labour market and an equally difficult financial situation.

Recent progress and market analysis of anticoagulant drugs.

This review describes epidemiology of thromboembolic disease in China and abroad, evaluates trends in the development of anticoagulant drugs, and analyzes the market situation based on large amounts of accumulated data. Specifically, we describe advances in clinical application of anticoagulants and analyze the most commonly used anticoagulants in the market systematically.